Treatment of Patients with Recently Exacerbated Schizophrenia with Paliperidone Palmitate: A Pilot Study of Efficacy and Tolerability

BACKGROUND: Paliperidone palmitate is a long-acting, second-generation antipsychotic (SGA) indicated for the treatment of acute exacerbations and maintenance treatment of adults with schizophrenia. This study addressed the response to paliperidone palmitate in Latin American patients with acute symp...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Neuropsychiatr Dis Treat
Autors principals: Gattaz, Wagner F, Saracco-Alvarez, Ricardo, Daltio, Claudiane Salles, Van de Bilt, Martinus T, Ortegón, Jose Julian, Villaseñor-Bayardo, Sergio J, Louzã, Mario, Elkis, Helio, Soares, Bernardo, Cabrera Jaramillo, Patricia, Lawson, Fabio, Díaz-Galvis, Leonardo
Format: Artigo
Idioma:Inglês
Publicat: Dove 2020
Matèries:
Original Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7490440/
https://ncbi.nlm.nih.gov/pubmed/32982245
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/NDT.S233537
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars